Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Joyner

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Science (New York, N.Y.)|August 26, 2010
Deep-sea oil plume enriches indigenous oil-degrading bacteriaTerry C Hazen, Eric A Dubinsky, Todd Z DeSantis, et al.
Mbio|May 14, 2015
Natural bacterial communities serve as quantitative geochemical biosensorsMark B Smith, Andrea M Rocha, Chris S Smillie, et al.
Chemosphere|May 18, 2020
Characterization of subsurface media from locations up- and down-gradient of a uranium-contaminated aquiferJi-Won Moon, Charles J Paradis, Dominique C Joyner, et al.
American Heart Journal|June 20, 2006
Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events, , S Connolly, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Science (New York, N.Y.)|August 26, 2010
Deep-sea oil plume enriches indigenous oil-degrading bacteriaTerry C Hazen, Eric A Dubinsky, Todd Z DeSantis, et al.
Mbio|May 14, 2015
Natural bacterial communities serve as quantitative geochemical biosensorsMark B Smith, Andrea M Rocha, Chris S Smillie, et al.
Chemosphere|May 18, 2020
Characterization of subsurface media from locations up- and down-gradient of a uranium-contaminated aquiferJi-Won Moon, Charles J Paradis, Dominique C Joyner, et al.
American Heart Journal|June 20, 2006
Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events, , S Connolly, et al.
Pageof 7